Filing search / Pulmatrix, Inc. / "Community"

8-K

PULM Pulmatrix, Inc.

4 Mar 24

Regulation FD Disclosure

4:06pm

and/or distribute to the investment community and utilize at various industry and other conferences a slide presentation, which is attached hereto as Exhibit 99.1

8-K

PULM Pulmatrix, Inc.

8 Jan 24

Entry into a Material Definitive Agreement

9:00am

FD Disclosure. The Company also intends, from time to time, to present and/or distribute to the investment community and utilize at various industry

8-K

PULM Pulmatrix, Inc.

11 Jul 23

Pulmatrix Announces Submission of IND Application to FDA to Initiate a Phase 2 Trial of Investigational Drug PUR3100 to Treat Acute Migraine

9:05am

, from time to time, to present and/or distribute to the investment community and utilize at various industry and other conferences a slide presentation

8-K

PULM Pulmatrix, Inc.

14 Nov 22

Pulmatrix Announces Third Quarter 2022 Financial Results and Provides Corporate Update

6:17am

, from time to time, to present and/or distribute to the investment community and utilize at various industry and other conferences a slide

8-K

PULM Pulmatrix, Inc.

12 Jul 22

Pulmatrix Announces First Subject Dosed in Phase 1 Study of PUR3100 for Acute Migraine

9:00am

to the Company. The Company may, from time to time, present and/or distribute to the investment community and utilize the slide presentation at various industry

8-K

24l645ctni7tf07y

12 May 22

Pulmatrix Announces First Quarter 2022 Financial Results and Provides Corporate Update

9:15am

8-K

u38bxul osh

29 Mar 22

Pulmatrix Announces Year-End and Q4 Financial 2021 Results and Provides Corporate Update

9:15am

DEFA14A

vlza2gtw bs46jj

1 Feb 22

Additional proxy soliciting materials

9:10am

8-K

oqvdd2121wqe3fl s8iv

7 Dec 21

Regulation FD Disclosure

9:25am

8-K

97vp06zjn3dqyiw0g8

13 May 21

Regulation FD Disclosure

10:26am

8-K

cu7f3r74vz7nchawvs

12 Apr 21

Termination of a Material Definitive Agreement

9:15am

8-K

ieysa4efn0 p1yt7fzr

2 Dec 20

Regulation FD Disclosure

11:32am

8-K

4xse9b902p7h1

22 Sep 20

Regulation FD Disclosure

9:10am

8-K

zsq4q

17 Jun 20

Regulation FD Disclosure

8:30am

8-K

4vznndb2 txfvy9

24 Apr 20

Regulation FD Disclosure

4:26pm

8-K

9cpasr7crudkyclfi

13 Jan 20

Regulation FD Disclosure

8:45am

8-K

yk3bbdtxe

22 Aug 19

Regulation FD Disclosure

9:00am

8-K

EX-99.1

4s6u27

15 Apr 19

Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of PulmazoleTM

5:00pm

8-K

EX-99.1

8rcj2 ffv

1 Apr 19

Entry into a Material Definitive Agreement

4:16pm

8-K

iio15hhrixmh

1 Aug 18

Regulation FD Disclosure

3:31pm